RAPH (Raphael Pharmaceutical) Accounts Payable: $0.53 Mil (As of Mar. 2026)


RAPH Raphael Pharmaceutical Inc RAPH
37 GF Score
Price $1.40
! 2 Warning Signs
View Full Analysis

What is Raphael Pharmaceutical Accounts Payable?

Raphael Pharmaceutical RAPH 37 Accounts Payable is $0.53 Mil as of Mar. 2026. GuruFocus rates RAPH with a GF Score™ of 37/100. The stock has 2 warning signs investors should review.

Raphael Pharmaceutical's Accounts Payable for the quarter that ended in Mar. 2026 was $0.53 Mil.

Raphael Pharmaceutical's quarterly Accounts Payable declined from Sep. 2025 ($0.48 Mil) to Dec. 2025 ($0.16 Mil) but then increased from Dec. 2025 ($0.16 Mil) to Mar. 2026 ($0.53 Mil).

Raphael Pharmaceutical's annual Accounts Payable increased from Dec. 2023 ($0.07 Mil) to Dec. 2024 ($0.13 Mil) and increased from Dec. 2024 ($0.13 Mil) to Dec. 2025 ($0.16 Mil).

Raphael Pharmaceutical Accounts Payable Related Terms

Raphael Pharmaceutical Accounts Payable Historical Data

* Premium members only.

The historical data trend for Raphael Pharmaceutical's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Raphael Pharmaceutical Accounts Payable Chart

Raphael Pharmaceutical Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Accounts Payable
Get a 7-Day Free Trial 0.11 0.07 0.07 0.13 0.16

Raphael Pharmaceutical Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.38 0.47 0.48 0.16 0.53
RAPH
37GF Score
Raphael Pharmaceutical Inc RAPH
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Raphael Pharmaceutical Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of $0.53 Mil mean?
Raphael Pharmaceutical (RAPH) has a Accounts Payable of $0.53 Mil as of Mar. 2026. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Raphael Pharmaceutical and its competitors.
Is Raphael Pharmaceutical's Accounts Payable too high?
Raphael Pharmaceutical's current Accounts Payable is $0.53 Mil. Overall, Raphael Pharmaceutical has a GF Score™ of 37/100, reflecting its overall financial health beyond just this single metric.
How does Raphael Pharmaceutical's Accounts Payable compare to TXMD and AYTU?
Raphael Pharmaceutical's Accounts Payable of $0.53 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Drug Manufacturers company?
A good Accounts Payable depends on the Drug Manufacturers industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Raphael Pharmaceutical and its competitors. Raphael Pharmaceutical's current Accounts Payable is $0.53 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Raphael Pharmaceutical stock overvalued right now?
Raphael Pharmaceutical (RAPH) has a current Accounts Payable of $0.53 Mil. The current Accounts Payable is $0.53 Mil. Raphael Pharmaceutical's overall GF Score™ is 37/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Raphael Pharmaceutical (RAPH), the current Accounts Payable is $0.53 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Raphael Pharmaceutical Business Description

Address 4 Lui Paster, Tel Aviv-Jaffa, ISR, 6803605
Raphael Pharmaceutical Inc is a pharmaceutical drug research and development company focused on the discovery and clinical development of life-improving drug therapies based on cannabinoids, including cannabidiol, or CBD oil. Its product is RaphaWell, which includes CBG and Sesame Oil Supplement.
37GF Score

Get the complete analysis for RAPH

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.40
Price